DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
von Hagens C, Walter-Sack I, Goeckenjan M. et al.
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2).
Breast Cancer Res Treat 2017;
164: 359-369
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.